Uridine DNA/RNA Synthesis chemical

Cat.No.S2029

Uridine (NSC 20256,β-Uridine, Uridin) is a nucleoside, contains a uracil attached to a ribose ring via a β-N1-glycosidic bond.
Uridine DNA/RNA Synthesis chemical Chemical Structure

Chemical Structure

Molecular Weight: 244.2

Quality Control

Batch: S202901 DMSO]49 mg/mL]false]Water]49 mg/mL]false]Ethanol]Insoluble]false Purity: 99.99%
99.99

Chemical Information, Storage & Stability

Molecular Weight 244.2 Formula

C9H12N2O6

Storage (From the date of receipt)
CAS No. 58-96-8 Download SDF Storage of Stock Solutions

Synonyms NSC 20256,β-Uridine, Uridin Smiles C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O

Solubility

In vitro
Batch:

DMSO : 49 mg/mL (200.65 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : 49 mg/mL

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05474105 Recruiting
Ischemic Stroke
Barts & The London NHS Trust|Queen Mary University of London|Nutricia Research
July 11 2023 Not Applicable
NCT05655780 Recruiting
Colorectal Neoplasms
Maastricht University Medical Center|Maastricht University|Wageningen University & Research|Fontys Hogeschool|Amsterdam UMC - Locatie AMC|Erasmus Medical Center|Catharina Ziekenhuis|University of North Carolina (USA)|Oncology patientenpanel MUMC|Stichting Kanker.nl|Van Weel-Bethesda Ziekenhuis|VieCuri Medisch Centrum voor Noord-Limburg|Gelderse Vallei Hospital|Danone Nutricia Research|Clinical Trial Center Maastricht B.V.|Dutch Colorectal Cancer Group (DCCG)|Prospectief Landelijk CRC Cohort (PLCRC)|CRC-guideline committee|CZ zorgverzekeraar|Landelijke Werkgroep Diëtisten Oncologie (LWDO)
January 9 2023 --
NCT04800159 Recruiting
HIV|Cannabis Use
University of California San Diego|Center for Medicinal Cannabis Research
February 19 2021 Phase 2
NCT04609826 Active not recruiting
Acute Myeloid Leukemia|Myelodysplastic Syndromes|Chronic Myelomonocytic Leukemia
Janssen Research & Development LLC
November 26 2020 Phase 1
NCT02249468 Terminated
Mild and Moderate Alzheimer''s Disease|Cognitively Healthy People
Danone Nutricia Research
October 2014 --

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Signaling Pathway Map